Mutations in OPA1 have been implicated in various diseases, with the most common being autosomal dominant optic atrophy (ADOA) and dominant optic atrophy plus syndrome (DOA+), the latter of which is characterized by multisystem neurodegeneration including myopathy, ataxia, and dementia. The gene discussed is OPA1; the disease is myopathy.